UMB-32

Overview

UMB-32, a potent, selective BRD4 inhibitor, binds BRD4 with the K d of 550 nM, and IC 50 of 637 nM. UMB-32 also shows potency against TAF1, a bromodomain-containing transcription factor.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Epigenetic Reader Domain

Product Information

• Catalog No.: HY-117997
• CAS No.: 1635437-39-6
• Molecular Formula: C21H23N5O
• Molecular Weight: 361.44
• Purity: 99.11%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (6.92 mM); Clear solution
• Availability: In-stock

Source

Original product source